RORER INT HOLDINGS has a total of 27 patent applications. Its first patent ever was published in 1987. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are EJSAJ AR END DI MENEDZHMENT KO LTD, CLEVEXEL PHARMA and NAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 12 | |
#2 | Canada | 5 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | Australia | 3 | |
#5 | Finland | 1 | |
#6 | Norway | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Campbell Henry F | 5 |
#2 | Spada Alfred P | 4 |
#3 | Gilon Chaim | 4 |
#4 | Levitzki Alexander | 4 |
#5 | Gazit Aviv | 4 |
#6 | Eilat Dan | 3 |
#7 | Regan John R | 3 |
#8 | Youssefyeh Raymond D | 3 |
#9 | Kuhla Donald E | 3 |
#10 | Molino Bruce F | 3 |
Publication | Filing date | Title |
---|---|---|
AU7854291A | Styryl compounds which inhibit egf receptor protein tyrosine kinase | |
EP0460064A1 | Therapeutic aerosol formulations | |
EP0494140A1 | Dibenzofurancarboxamides |